IMMUNE PHARMACEUTICALS INC

Profile

Company Names

IMMUNE PHARMACEUTICALS INC

Addresses

708 THIRD AVENUE, SUITE 210, NEW YORK, NY 10017

Phone Numbers

914-606-3500

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$11,720,475.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2014-03-14 
$11,720,475.00 
$11,720,475.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
 
KAZADO 
DIRECTOR
IMMUNE PHARMACEUTICALS INC
ISAAC 
 
KOBRIN 
DIRECTOR
IMMUNE PHARMACEUTICALS INC
RENE 
 
LERER 
DIRECTOR
IMMUNE PHARMACEUTICALS INC   |  ONEX YORK HOLDINGS CORP.   |  AVAILITY, L.L.C.
DAVID 
 
SIDRANSKY 
DIRECTOR
ALFACELL CORP   |  KV PHARMACEUTICAL CO /DE/   |  ROSETTA GENOMICS LTD.   |  MORRIA BIOPHARMACEUTICALS PLC   |  CHAMPIONS ONCOLOGY, INC.   |  CELSUS THERAPEUTICS PLC.   |  Y LABS, INC.   |  IMMUNE PHARMACEUTICALS INC   |  ORGENESIS INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  GALMED PHARMACEUTICALS LTD.   |  ISRAEL BIOTECH FUND II, L.P.   |  ADVAXIS, INC.   |  AYALA PHARMACEUTICALS, INC.
ANA 
 
STANCIC 
DIRECTOR
CHAMPIONS ONCOLOGY, INC.   |  IMMUNE PHARMACEUTICALS INC
DANIEL 
G. 
TEPER 
EXECUTIVE OFFICER, DIRECTOR
IMMUNE PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-04-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-03-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CHARDAN CAPITAL MARKETS LLC
120128